Prothena Corp Public PRTA
NASDAQ PRTA
$8.43 -0.07 (-0.88%)
As of: Oct 21, 2026 · 10:07 AM EDT

Prothena Corp Public (PRTA) EV to EBITDA (2014 - 2022)

Updated

Prothena Corp Public's EV to EBITDA was 17.38 in Q1 2022, down 26.4% from the prior quarter.

Analysis

Prothena Corp Public (PRTA) EV to EBITDA (2014 - 2022) Analysis & Trends

On a trailing twelve-month basis, Prothena Corp Public's EV to EBITDA was -6.14 through Mar 31, 2022; for FY2021, it came in at 23.61.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,129.39 Bn 1,097.98 Bn 19.71 Bn
2 Johnson & Johnson 615.68 Bn 534.21 Bn 17.26 Bn
3 AbbVie 505.77 Bn 478.89 Bn 12.70 Bn
4 Merck 366.50 Bn 320.88 Bn 12.21 Bn
5 Novartis Ag 297.33 Bn 261.32 Bn 11.24 Bn
6 Astrazeneca 261.02 Bn 234.71 Bn 12.86 Bn
7 Amgen 235.47 Bn 190.87 Bn 7.24 Bn
8 Gilead Sciences 189.20 Bn 163.40 Bn 6.22 Bn
9 Pfizer 170.20 Bn 116.85 Bn 10.94 Bn
10 Prothena Corp Public 439.32 Mn -816.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 454.98
Mar 31, 2022 16.01
Dec 31, 2021 21.91
Sep 30, 2021 33.25
Jun 30, 2014 7,086.09
API Access

Prothena Corp Public EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=PRTA&period=max&api_key=YOUR_API_KEY